COMMUNIQUÉS West-GlobeNewswire

Ceapro Inc. Reports 2018 Second Quarter and Six-Month Financial Results and Operational Highlights
28/08/2018
EDMONTON, Alberta, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. ( TSX-V: CZO) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients [...]
Grown Rogue Brand Fills an Important Marketing Void with its Seed-to-Experience Model -- CFN Media
28/08/2018
Seattle, Washington, Aug. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]
Retail is King in the Burgeoning Cannabis Industry -- CFN Media
28/08/2018
SEATTLE, Aug. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Why Are Beverage Companies So Interested in Cannabis? -- CFN Media
28/08/2018
SEATTLE, Aug. 28, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
Biohit Oyj: Managers' Transactions
28/08/2018
BIOHIT OYJ MANAGERS’ TRANSACTIONS 28 AUGUST 2018 Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Semi Korpela Position: Chief Executive Officer Issuer: Biohit Oyj LEI: [...]
CV Sciences, Inc. Responds to Class Action Lawsuit
28/08/2018
LAS VEGAS, Aug. 28, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) has been informed of a class action lawsuit filed against the Company that alleges [...]
Delcath Announces Extension of Rights Offering Period to September 26, 2018
28/08/2018
NEW YORK, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH ), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that it has completed the [...]
Avinger Announces Participation in Upcoming Investor Conferences
28/08/2018
REDWOOD CITY, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that management of Avinger will [...]
Galectin Therapeutics to Present at H.C. Wainwright 20th Annual Global Investment Conference
28/08/2018
NORCROSS, Ga., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold H. Shlevin, the Company’s [...]
Arbutus to Participate at the 2018 B. Riley FBR Healthcare Conference
28/08/2018
WARMINSTER, Pa., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael Sofia, Arbutus [...]
AzurRx BioPharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference on September 5th
28/08/2018
BROOKLYN, N.Y., Aug. 28, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
Yield10 Bioscience to Present at the 20th Annual Rodman and Renshaw Global Investment Conference in New York City September 4-6, 2018
28/08/2018
WOBURN, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a company focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security [...]
Hemispherx Releases Recently Manufactured Ampligen for Pancreatic Cancer Early Access Program in the Netherlands to Fill Stock Order
28/08/2018
ORLANDO, Fla., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) announced today that the new Ampligen batch manufactured earlier this year is now released for patients' use in the [...]
Onconova Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference in New York City
28/08/2018
NEWTOWN, Pa., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]
ChemoCentryx to Present at Two Upcoming Investor Conferences
28/08/2018
MOUNTAIN VIEW, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor [...]
Cytokinetics Awards Inaugural Communications Fellowship To The ALS Association Golden West Chapter
28/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that The ALS Association Golden West Chapter is the inaugural recipient of the Cytokinetics [...]
Viveve to Present at 20th Annual Rodman & Renshaw Global Investment Conference
28/08/2018
ENGLEWOOD, Colo., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive [...]
Avid Bioservices to Exhibit at the 2018 BioProcess International Conference & Exhibition
28/08/2018
-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- TUSTIN, Calif., Aug. 28, 2018 [...]
Sirona Biochem Receives $500,000 USD Milestone Payment from Wanbang Biopharmaceuticals
28/08/2018
VANCOUVER, British Columbia, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) (the “ Company ”) announced that it has received the $500,000 USD milestone payment from partner [...]

Pages